Background Treatment Clinical Trials
2 recruitingDrug
Not Applicable1Phase 11Phase 21
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participants
Periprosthetic Joint Infection (PJI)
TenNor Therapeutics Inc.33 enrolled1 locationNCT06889701
Recruiting
Not Applicable
ConsideRAte Study - Splenic Stimulation for RA
Rheumatoid Arthritis
Galvani Bioelectronics28 enrolled14 locationsNCT05003310